Carnitine, acylcarnitine and amino acid profiles analyzed by tandem mass spectrometry in a surfactant/virus mouse model of acute hepatic encephalopathy

Chemosphere

Volumn 68, Issue 9, 2007, Pages 1692-1698

  Murphy, M G ^a   Crocker, J F S ^a   O'Regan, P ^a   Lee, S H S ^a   Geldenhuys, L ^a   Dooley, K ^a   Al Khalidi, M ^a   Acott, P D ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Acute hepatic encephalopathy; Dicarboxylic acylcarnitine; Hydroxy acylcarnitine; Industrial surfactant; Mouse adapted human influenza B (Lee) virus; Toximul 3409F

Indexed keywords

BIOMARKERS; BIOMEDICAL ENGINEERING; MAMMALS; SURFACE ACTIVE AGENTS; VIRUSES;

ACUTE HEPATIC ENCEPHALOPATHY; DICARBOXYLIC ACYLCARNITINE; HYDROXY-ACYLCARNITINE; INDUSTRIAL SURFACTANT; MOUSE-ADAPTED HUMAN INFLUENZA B (LEE) VIRUS;

LIVING SYSTEMS STUDIES;

ACYLCARNITINE; AMINO ACID; CARNITINE; DICARBOXYLIC ACID; PROPIONYLCARNITINE; SURFACTANT;

BIOMARKERS; BIOMEDICAL ENGINEERING; LIVING SYSTEMS STUDIES; MAMMALS; SURFACE ACTIVE AGENTS; VIRUSES;

ALKALOID; AMINO ACID; INFLUENZA; MASS SPECTROMETRY; METABOLITE; ORGANIC COMPOUND; RODENT; SURFACTANT; VIRUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GLUCOSE BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; INFLUENZA VIRUS B; INTRACRANIAL PRESSURE; LETHAL DOSE; LIVER FAILURE; MALE; MORTALITY; MOUSE; NONHUMAN; PERINATAL PERIOD; PROTEIN ANALYSIS; TANDEM MASS SPECTROMETRY; VIRUS INFECTION; WEIGHT REDUCTION;

INFLUENZA B VIRUS; MUS;

EID: 34250013086     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2007.03.049     Document Type: Article

References (34)

1. Acott P.D., Crocker J.F.S., Lee S.H.S., Evans J., O'Regan P., Al-Khalidi M., Geldenhuys L., and Murphy M.G. Effects of insulin-like growth factor-type 1 on weight gain and hepatic glycogen during early development in a surfactant/virus mouse model of acute liver failure: correlation with mortality. Hepatol. Res. 29 (2004) 42-50
2. Arrigoni-Martelli E., and Caso V. Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drugs Exp. Clin. Res. 27 (2001) 27-49
3. Berryman D., Houde F., DeBlois C., and O'Shea M. Nonylphenolic compounds in drinking and surface waters downstream of treated textile and pulp and paper effluents: a survey and preliminary assessment of their potential effects on public health and aquatic life. Chemosphere 56 (2004) 247-255
4. Brown R.E., and Forman D.T. The biochemistry of Reye's syndrome. CRC Crit. Rev. Clin. Lab. Sci. 17 (1982) 247-297
5. Casteels-Van Daele M., Van Geet C., Wouters C., and Eggermont E. Reye syndrome revisited: a descriptive term covering a group of heterogeneous disorders. Eur. J. Pediatr. 159 (2000) 641-648
6. Chace D.H., Kalas T.A., and Naylor E.W. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin. Chem. 49 (2003) 1797-1817
7. Chen Y., Mizuguchi H., Yao D., Ide M., Kuroda Y., Shigematsu Y., Yamaguchi S., Yamaguchi M., Kinoshita M., and Kido H. Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy. FEBS Lett. 579 (2005) 2040-2044
8. Crocker, J.F.S., Ozere, R.L., 1979. The incidence and etiology of Reye's syndrome in eastern Canada. In: Crocker, J.F.S. (Ed.), Reye's Syndrome II. Natl. Reye's Synd. Found., Bryon OH, pp. 3-12.
9. Crocker J.F.S., Ozere R.L., Safe S.H., Digout S.C., Rozee K.R., and Hutzinger O. Lethal interaction of ubiquitous insecticide carrier with virus. Science 192 (1976) 1351-1353
10. Crocker J.F.S., Renton K.W., Lee S.H., Rozee K.R., Digout S.C., and Malatjalian D.A. Biochemical and morphological characteristics of a mouse model of Reye's syndrome induced by the interaction of influenza B virus and a chemical emulsifier. Lab. Invest. 54 (1986) 32-40
11. Crocker J.F.S., Lee S.H.S., Love J.A., Malatjalian D.A., Renton K.W., Rozee K.R., and Murphy M.G. Surfactant-potentiated increases in intracranial pressure in a mouse model of Reye's syndrome. Exp. Neurol. 111 (1991) 95-97
12. Glasgow J.F.T., Middleton B., Moore R., Gray A., and Hill J. The mechanism of β-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls. Biochim. Biophys. Acta 1454 (1999) 115-125
13. Hug G., Bosken J., Bove K., Linnemaann C.C., and McAdams L. Reye's syndrome simulacra in liver of mice after treatment with chemical agents and encephalomyocarditis virus. Lab. Invest. 45 (1981) 89-109
14. Ibdah J.A., Paul H., Zhao Y., Binford S., Salleng K., Cline M., Matern D., Bennett M.J., Rinaldo P., and Strauss A.W. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J. Clin. Invest. 107 (2001) 1403-1409
15. Kibayashi M., Nagao M., and Chiba S. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats. Pediatr. Int. 41 (1999) 52-60
16. Lieu Y.K., Hsu B.Y.L., Price W.A., Corkey B.E., and Stanley C.A. Carnitine effects on coenzyme A profiles in rat liver with hypoglycin inhibition of multiple dehydrogenases. Am. J. Physiol. 272 (1997) E359-E366
17. Liu J., Head E., Kuratsune H., Cotman C.W., and Ames B.N. Comparison of the effects of l-carnitine and acetyl-l-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann. N.Y. Acad. Sci. 1033 (2004) 117-131
18. Matern D., Strauss A.W., Hillman S.L., Mayatepek E., Millington D.S., and Trefz F.-K. Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis. Pediatr. Res. 46 (1999) 45-49
19. McArthur B., Sarnaik A.P., and Mitchell R.A. Short-chain fatty acids and encephalopathy of Reye's syndrome. Neurology 34 (1984) 831-934
20. Murphy M.G., Archambault-Schertzer L., VanKessel J., Digout S.C., Malatjalian D.A., and Crocker J.F.S. Hepatic lipid abnormalities in a chemical/viral mouse model for Reye's syndrome. Lipids 22 (1987) 217-223
21. Murphy M.G., Crocker J.F.S., and Her H. Abnormalities in hepatic fatty-acid metabolism in a surfactant/influenza B virus mouse model for acute encephalopathy. Biochim. Biophys. Acta 1315 (1996) 208-216
22. Murphy M.G., Crocker J.F.S., Lee S.H.S., Acott P., and Her H. Sequestration of coenzyme A by the industrial surfactant, Toximul MP8. A possible role in the inhibition of fatty-acid β-oxidation in a surfactant/influenza B virus mouse model for acute hepatic encephalopathy. Biochim. Biophys. Acta 1361 (1997) 103-113
23. Murphy M.G., Al-Khalidi M., Crocker J.F.S., Lee S.H., O'Regan P., and Acott P.D. Two formulations of the industrial surfactant, Toximul, differentially reduce mouse weight gain and hepatic glycogen in vivo during early development: effects of exposure to influenza B virus. Chemosphere 59 (2005) 235-246
24. Orlowski J.P., Hanhan U.A., and Fiallos M.R. Is aspirin a cause of Reye's syndrome? A case against. Drug Safety 25 (2002) 225-231
25. Rashed M.S., Bucknall M.P., Little D., Awad A., Jacob M., Alamoudi M., Alwattar M., and Ozand P.T. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin. Chem. 43 (1997) 1129-1141
26. Roe, C.R., Millington, D.S., Maltby, D.A., Bohan, T.P., 1985. Relative carnitine insufficiency in Reye's syndrome and related metabolic disorders. In: Pollack, J.D. (Ed.), Reye's Syndrome IV. Natl. Reye's Syndrome Found., Bryan Ohio, pp. 201-215.
27. Sabik H., Gagné F., Blaise C., Marcogliese D.J., and Jeannot R. Occurrence of alkylphenol polyethoxylates in the St Lawrence River and their bioconcentration by mussels (Elliptio complanata). Chemosphere 51 (2003) 349-356
28. Schuler A.M., and Wood P.A. Mouse models for disorders of mitochondrial fatty acid beta-oxidation. ILAR J. 43 (2002) 57-65
29. Silva M.F.B., Selhorst J., Overmars H., van Gennip A.H., Maya M., Wanders R.J.A., Taves de Almeida I., and Duran M. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS. Clin. Biochem. 34 (2001) 635-638
30. Spiekerkoetter U., Tokunaga C., Wendel U., Mayatepek E., Exil V., Duran M., Wijburg F.A., Wanders R.J.A., and Strauss A.W. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress. Eur. J. Clin. Invest. 34 (2004) 191-196
31. van Vlies N., Tian L., Overmars H., Bootsma A.H., Kulik W., Wanders R.J.A., Wood P.A., and Vaz F.M. Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase deficient mouse. Biochem. J. 387 (2005) 185-193
32. Visentin M., Salmona M., and Tacconi M.T. Reye's and Reye-like syndromes, drug-related diseases? (Causative agents, etiology, pathogenesis, and therapeutic approaches). Drug Metab. Rev. 27 (1995) 517-539
33. Zoller U., Plaut I., and Hushan M. The case of the nonionic alkylphenol ethoxylates in the Mediterranean Sea region: Is there a problem?. Water Sci. Tech. 50 (2004) 79-84
34. Zytkovicz T.H., Fitzgerald E.F., Marsden D., Larson C.A., Shih V.E., Johnson D.M., Strauss A.W., Coneau A.M., Eaton R.B., and Grady G.F. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin. Chem. 47 (2001) 1945-1955